Chugai Pharma (4519) - ALEX Trials for Alecensa a Success
Chugai Pharmaceutical (4519 JP) completed the clean sweep on Phase III trials for Alecensa. The latest data, from the ALEX trial, showed its...
163 Views
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
297 Views
Chugai Pharmaceutical: Update Ahead of Summer Data Releases
The excitement at Chugai Pharmaceutical (4519 JP) is palpable for all to see, and you quickly get the impression at any meeting that the company is...
149 Views
Drug Price Regulation in Japan
Legislation and regulation in Japan tend to be evolutionary rather than revolutionary. You get the odd inflection point coming out of nowhere – the...
167 Views
The Week That Was in NorthAsia@Smartkarma
This is the third report of "The Week That Was in North Asia@Smartkarma". This is a collaborative report among Mio Kato, CFA, Sanghyun Park,...
348 Views